Today's Mallinckrodt Pharmaceuticals combines more than 146 years of expertise with the determined focus needed to solve the complex specialty pharmaceutical challenges of today. Whether it's the production of medicines for pain and attention deficit hyperactivity disorder, the development of products that treat central nervous system conditions or quality imaging products, we are working to make complex products simpler, safer and better for patients.

Patents 6,679show all

  • 1,494
    A61K - Preparations for medical, dental, or toilet purposes
  • 1,122
    A61M - Devices for introducing media into, or onto, the body
  • 769
    C07D - Heterocyclic compounds
  • 552
    A61B - Diagnosis
  • 548
    C07C - Acyclic or carbocyclic compounds
  • 228
    G06F - Electric digital data processing
  • 214
    C11D - Detergent compositions
  • 198
    G03F - Photomechanical production of textured or patterned surfaces, e.g. for printing, for processing of semiconductor devices
  • 192
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 175
    Y02A - Technologies for adaptation to climate change

Clinical Trials 228show all

54Phase 354Phase 449Phase 224Phase 118N/A20Other

SEC Filings show all


107
8-K

19
10-Q

6
10-K

Contact Information

Damastown
Ireland